SEC Form 4 · accession 0001354488-16-008215
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cora M Tellez
Director
Period of report
Aug 19, 2016
Accepted (ET)
Aug 23, 2016 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 19, 2016 | P | 12,500 | $1.727 | A | 109,486 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy Common Stock)F2 | $2.05 | holding | — | — | — | — | Apr 3, 2024 | Common Stock | 30,000 | 30,000 | D |
| Stock Option (Right to by Common Stock)F3 | $5.62 | holding | — | — | — | — | Mar 1, 2025 | Common Stock | 50,000 | 50,000 | D |
| Phantom StockF4 | $0.00 | holding | — | — | — | — | — | Common Stock | 4,205 | 4,205 | D |
| Phantom StockF4 | $0.00 | holding | — | — | — | — | — | Common Stock | 2,873 | 2,873 | D |
| Phantom StockF4 | $0.00 | holding | — | — | — | — | — | Common Stock | 1,371 | 1,371 | D |
| Phantom StockF4 | $0.00 | holding | — | — | — | — | — | Common Stock | 2,868 | 2,868 | D |
| Phantom StockF4 | $0.00 | holding | — | — | — | — | — | Common Stock | 3,645 | 3,645 | D |
| Stock Option (Right to buy Common Stock)F3 | $1.91 | holding | — | — | — | — | Feb 21, 2026 | Common Stock | 100,000 | 100,000 | D |
| Phantom StockF4 | $0.00 | holding | — | — | — | — | — | Common Stock | 4,104 | 4,104 | D |
| Phantom StockF4 | $0.00 | holding | — | — | — | — | — | Common Stock | 2,767 | 2,767 | D |
| Phantom StockF4 | $0.00 | holding | — | — | — | — | — | Common Stock | 4,335 | 4,335 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $1.63 to $1.74. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the trades were effected.
- F2These shares vest 1/3 on date of grant, 1/3 on first anniversary of date of grant and 1/3 on second anniversary of date of grant.
- F3The options vest in full on the first anniversary of the date of grant.
- F4Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
Remarks
Form 4 - Cora Tellez 8-19-2016